Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients

Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients

Zhefeng Liu,1,* Lin Wu,2,* Jun Cao,3 Zhe Yang,4 Chengzhi Zhou,5 Liming Cao,6 Hao Wu,7 Haibo Shen,8 Meiling Jin,9 Yong Zhang,1 Xinru Mao,10 Jianxing Xiang,10 Ke Ma,10 Bing Li,11 Tengfei Zhang,10 Yi Hu1 1Department of Oncology, Chinese PLA General Hospital, Beijing, People’s Republic of Chi...

Full description

Bibliographic Details
Main Authors: Liu Z, Wu L, Cao J, Yang Z, Zhou C, Cao L, Wu H, Shen H, Jin M, Zhang Y, Mao X, Xiang J, Ma K, Li B, Zhang T, Hu Y
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
ERBB2
lung cancer
afatinib
survival
heterogeneity
Online Access:https://www.dovepress.com/clinical-characterization-of-erbb2-exon-20-insertions-and-heterogeneit-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-characterization-of-erbb2-exon-20-insertions-and-heterogeneit-peer-reviewed-article-OTT

Similar Items